scispace - formally typeset
H

Hitomi Yuzawa

Researcher at Toho University

Publications -  40
Citations -  184

Hitomi Yuzawa is an academic researcher from Toho University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 5, co-authored 31 publications receiving 112 citations. Previous affiliations of Hitomi Yuzawa include Memorial Hospital of South Bend.

Papers
More filters
Journal ArticleDOI

Comparison of late potentials for 24 hours between Brugada syndrome and arrhythmogenic right ventricular cardiomyopathy using a novel signal-averaging system based on Holter ECG.

TL;DR: LP characteristics detected by the Holter-based signal-averaged ECG system over 24 hours differ between BS and ARVC patients, which may imply that mechanisms of lethal ventricular arrhythmia in BS may be more correlated with autonomic abnormality than that of ARVC.
Journal ArticleDOI

Assessment of the bleeding risk of anticoagulant treatment in non-severe frail octogenarians with atrial fibrillation

TL;DR: In non-severe frail octogenarians with AF taking OACs, having a low BMI was the most significant factor associated with the development of bleeding and remained an independent risk factor for bleeding in the patients treated with appropriately adjusted-dose Oacs.
Journal ArticleDOI

Comparative analysis of the therapeutic effects of long‐acting and short‐acting loop diuretics in the treatment of chronic heart failure using 123I‐metaiodobenzylguanidine scintigraphy

TL;DR: This study was performed to compare therapeutic effects of two loop diuretics, long‐acting azosemide and short‐acting furosemide, using 123I‐metaiodobenzylguanidine (123I‐MIBG) scintigraphy.
Journal ArticleDOI

Assessment of a novel transdermal selective β1-blocker, the bisoprolol patch, for treating frequent premature ventricular contractions in patients without structural heart disease.

TL;DR: The transdermal bisoprolol patch was effective for a PVC reduction in patients with P-PVCs, particularly in those with faster mean HRs, and demonstrated a stable PVC-reducing effect during the 24-hour period in the P-pVC group.
Journal ArticleDOI

Early electrocardiographic indices for predicting chronic doxorubicin-induced cardiotoxicity.

TL;DR: This study indicated that T-wave changes and QTa prolongation may be useful as an early indicator before the onset of CTRCD in patients with chronic doxorubicin-induced cardiotoxicity.